Article
RRM1 domain of the splicing oncoprotein SRSF1 is required for MEK1-MAPK-ERK activation and cellular transformation.
Carcinogenesis - 1 Nov 2013
Shimoni-Sebag Ariel, Lebenthal-Loinger Ilana, Zender Lars, Karni Rotem
Abstract excerpt
Alternative splicing regulators have emerged as new players in cancer development, modulating the activities of many tumor suppressors and oncogenes and regulating the signaling pathways. However, little is known about the mechanisms by which these oncogenic splicing factors lead to cellular transformation. We have shown previously that the splicing factor serine and arginine splicing factor 1 (SRSF1; SF2/ASF) is...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
